Furthermore, we quantified MAG immunoreactivity in the white matter as loss of the minor myelin proteins has been described as an early and sensitive biomarker for myelin degeneration in MS demyelinating lesions (Popescu and Lucchinetti, 2012). Here, MAG is linked to myeloid sarcoma.